Research Paper Volume 13, Issue 1 pp 794—812

Systematic construction and validation of an epithelial–mesenchymal transition risk model to predict prognosis of lung adenocarcinoma

Confirmation of the ERG signature via stratification of patients from the training set based on specific demographic and clinical features. (A) Age B) age ≥ 65 years; (C) male; (D) female; (E) stage I; (F) stage II; (G) stage III; (H) T2; (I) T3; (J) M0; and (K) N0.

Figure 7. Confirmation of the ERG signature via stratification of patients from the training set based on specific demographic and clinical features. (A) Age < 65 years; (B) age ≥ 65 years; (C) male; (D) female; (E) stage I; (F) stage II; (G) stage III; (H) T2; (I) T3; (J) M0; and (K) N0.